Athina Karampela
Overview
Explore the profile of Athina Karampela including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mytareli C, Ziogas D, Karampela A, Papalexis P, Siampanopoulou V, Lafioniatis A, et al.
Cancers (Basel)
. 2023 Apr;
15(7).
PMID: 37046677
Immune checkpoint inhibitors (ICIs) have been approved for the treatment of many cancers, either in adjuvant or metastatic settings. Regarding safety, endocrine adverse events (AEs) are some of the most...
2.
Angelousi A, Papalexis P, Karampela A, Marra M, Misthos D, Ziogas D, et al.
Exp Ther Med
. 2022 Dec;
25(1):10.
PMID: 36561623
Immune checkpoint inhibitors (ICIs), including anti-programmed cell death protein 1 (PD-1), anti-programmed cell death protein ligand 1 (PD-L1) and anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) monoclonal antibodies, are novel therapeutic agents...
3.
Chatzi S, Karampela A, Spiliopoulou C, Boutzios G
Hormones (Athens)
. 2021 Oct;
21(1):177-179.
PMID: 34686971
No abstract available.